These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 28639298)

  • 1. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.
    O'Dwyer M; Peklar J; McCallion P; McCarron M; Henman MC
    BMJ Open; 2016 Apr; 6(4):e010505. PubMed ID: 27044582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication and supplement use in older people with and without intellectual disability: An observational, cross-sectional study.
    Peklar J; Kos M; O'Dwyer M; McCarron M; McCallion P; Kenny RA; Henman MC
    PLoS One; 2017; 12(9):e0184390. PubMed ID: 28877256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and associated factors of problem behaviours among older adults with intellectual disabilities in Ireland.
    O'Dwyer C; McCallion P; Burke É; Carroll R; O'Dwyer M; McCarron M
    Res Dev Disabil; 2018 Sep; 80():192-204. PubMed ID: 29880319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
    O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of behavioral and psychiatric symptoms in older adults with intellectual disability.
    Eady N; Courtenay K; Strydom A
    Drugs Aging; 2015 Feb; 32(2):95-102. PubMed ID: 25573538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of psychotropic medications in adults with intellectual disability: a scoping review.
    Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
    Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review.
    Moon S; Watkins L; O'Dwyer M; Shankar R
    Expert Rev Neurother; 2024 Nov; 24(11):1097-1105. PubMed ID: 39160772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic medicines' prevalence, patterns and effects on cognitive and physical function in older adults with intellectual disability in Ireland: longitudinal cohort study, 2009-2020.
    Odalović M; Gorman A; Paul A; McCallion P; Burke É; MacLachlan M; McCarron M; Henman MC; Moran M; O'Connell J; Walsh M; Shankar R; Ryan C; O'Dwyer M
    BJPsych Open; 2024 Feb; 10(2):e39. PubMed ID: 38297892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription errors in older individuals with an intellectual disability: prevalence and risk factors in the Healthy Ageing and Intellectual Disability Study.
    Zaal RJ; van der Kaaij AD; Evenhuis HM; van den Bemt PM
    Res Dev Disabil; 2013 May; 34(5):1656-62. PubMed ID: 23501585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
    Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
    Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic medication and psychotherapeutic treatment of adults with intellectual disabilities (PROMPT-ID): a cross-sectional, epidemiological study in Saxony, Germany.
    Koch A; Dobrindt J; Schützwohl M
    BMJ Open; 2018 Dec; 8(12):e025947. PubMed ID: 30573492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and patterns of antipsychotic use and their associations with mental health and problem behaviours among older adults with intellectual disabilities.
    O'Dwyer C; McCallion P; Henman M; McCarron M; O'Leary E; Burke E; O'Connell J; O'Dwyer M
    J Appl Res Intellect Disabil; 2019 Jul; 32(4):981-993. PubMed ID: 31038275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of psychotropic medication and factors associated with antipsychotic treatment in adults with intellectual disabilities: a cross-sectional, epidemiological study in Germany.
    Koch AD; Dobrindt J; Schützwohl M
    J Intellect Disabil Res; 2021 Feb; 65(2):186-198. PubMed ID: 33393123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.